查詢結果分析
相關文獻
- Should Rectosigmoid Junction Cancer Be Classified as Colon or Rectal Cancer in pT1-3N+M0 Cases? Clinical Results of Different Adjuvant Therapeutic Modalities
- 子宮頸癌的預後因素及化學治療在子宮頸癌治療的角色
- Clinical Characteristics of and Response to Combination Chemotherapy and Subsequent Application of International Prognostic Index in Non-Hodgkin's Lymphoma--an Experience from a Medical Center in Southern Taiwan
- 小細胞型肺癌以鎝-99mMIBI胸部造影來評估化學治療反應與病人預後關係的初步報告
- Krukenberg Tumor:Analysis of 15 Cases--Surgery, Chemotherapy, Prognosis
- Beta-Human Chorionic Gonadotropin Secreting Germinoma Refractory to Multi-Modality Treatment
- Metastatic Urothelial Carcinoma of the Bladder with Lymph Node-only Metastasis Treated with M-VAC (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) Has a Better Survival than GC (Gemcitabine and Cisplatin)
- 臺灣兒童惡性骨肉瘤簡介及治療現況
- Outcome of Advanced Primary Fallopian Tube Adenocarcinoma
- Should Rectosigmoid Junction Cancer Be Classified as Colon or Rectal Cancer in pT3N0M0 Cases? Clinical Results under Different Adjuvant Therapeutic Modalities
頁籤選單縮合
題 名 | Should Rectosigmoid Junction Cancer Be Classified as Colon or Rectal Cancer in pT1-3N+M0 Cases? Clinical Results of Different Adjuvant Therapeutic Modalities=在病理期別T1-3N+M0的直腸乙狀結腸連接處惡性腫瘤應視為大腸癌還是直腸癌治療:不同輔助性治療的臨床結果 |
---|---|
作 者 | 許尊堯; 馮已榕; 鄭立勤; 田宇峯; 周家麟; | 書刊名 | 中華民國大腸直腸外科醫學會雜誌 |
卷 期 | 31:3 2020.09[民109.09] |
頁 次 | 頁195-203 |
分類號 | 416.245 |
關鍵詞 | 病理期別T1-3N+M0的直腸乙狀結腸連接處惡性腫瘤; 同步放射及化學治療; 化學治療; 預後; pT1-3N+M0 rectosigmoid colon cancer; Concurrent chemoradiotherapy; Adjuvant chemotherapy; FOLFOX; Prognosis; |
語 文 | 英文(English) |